Could a blood pressure drug slow Alzheimer's? new trial begins

NCT ID NCT06362707

First seen May 13, 2026 · Last updated May 15, 2026 · Updated 1 time

Summary

This study tests whether fasudil, a drug that relaxes blood vessels, can improve memory and thinking in people with early Alzheimer's disease. About 200 participants will receive either fasudil or a placebo for 12 months. Researchers will measure changes in memory, brain activity, and blood markers to see if the drug slows the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Akershus Hospital:

    NOT_YET_RECRUITING

    Oslo, Oslo, Norway

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Haraldsplass Deaconess Hospital

    ENROLLING_BY_INVITATION

    Bergen, Vestland, Norway

  • Haugesund Hospital

    NOT_YET_RECRUITING

    Haugesund, Rogaland, Norway

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • St. Olavs Hospital:

    NOT_YET_RECRUITING

    Trondheim, Trøndelag, Norway

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Stavanger University Hospital

    RECRUITING

    Stavanger, Rogaland, Norway

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

  • University Hospital of North Norway

    NOT_YET_RECRUITING

    Tromsø, Nordland, Norway

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.